The use of a certain phytocannabinoid (The Supplement That Shall Not Be Named* – TSTSNBN) as a dietary supplement in the United States is rapidly increasing, but information about patient expectations, beliefs, attitudes, and self-efficacy is lacking. Knowledge about these constructs is an important factor to improving public health. Health behavior theories provide framework within which to identify patient attitudes and beliefs, as well as to explain health related decisions. While these constructs are used widely in other populations, they have not yet been applied to users of TSTSNBN.
This cross-sectional study uses the Theory of Reasoned Action and the Social Cognitive Theory to identify the expectations, attitudes, and beliefs about supplementation with TSTSNBN for anxiety, pain, and insomnia among existing users of complementary and alternative medicine (CAM). Findings from this research will provide context explaining why people with chronic conditions seek this supplement, what expectations they have about the supplement, and what outcomes they experience.
This 10-month research project began January 2019 and is in the data analysis stage with results expected to be released December 2019. The total cost of the project is $48,000, which was funded by the Franklin School of Integrative Health Sciences.
*Why TSTSNBN? To ensure compliance with our ads servers and merchant account, and to reduce false positives in website scans.